JESSICA WERT: Open Payments
NPI 1083312532 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$176 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $176
Food & beverage: $176
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $65 |
| Eisai Inc. | 1 | $42 |
| Genentech USA, Inc. | 1 | $31 |
| Amgen Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: TREMFYA, Leqembi, Ocrevus Zunovo, KRYSTEXXA, NUCALA.
Industry payments across CO — which companies pay providers there.
